ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026
Breast cancer survivors' perspectives on a clinical decision tool to support individualized exercise prescriptions and discussions.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
13 authors.
Funding
Abstract
purposeTo examine breast cancer survivors' perspectives on the prototype (paper-draft) of a clinical decision tool to support individualized exercise prescriptions and discussions within clinical settings.
methodsA sample of ≥90 female breast cancer survivors aged ≥35 years across the U.S. were recruited to complete an online survey that collected data on survivors' characteristics and perspectives of a prototype of the tool. Survey items were adapted from validated pre-existing instruments and refined via cognitive interviews.
resultsNinety-eight of the 142 individuals screened were deemed eligible and completed the survey. Most breast cancer survivors agreed that a tool would be useful (84.7%) and increase confidence to discuss exercise with a healthcare provider (74.5%). Among tool uses, the highest agreement was found for education (84.1%) and encouragement to exercise (79.3%). Improving the ability to do everyday tasks (74.0%), quality-of-life (72.6%), and energy (71.4%) were rated as the top exercise benefits to include in a tool. Agreement on tool usefulness, uses, and inputs varied by survivors' demographic, clinical, and contextual characteristics. For example, agreement that a tool would increase their confidence to discuss exercise was lower among younger survivors (<50 years, 67.7%) than older survivors (≥50 years, 78.5%).
conclusionsAn evidence-based clinical decision tool offering individualized exercise information could support exercise prescriptions and discussions within clinical settings. However, a one-size-fits-all tool may not address existing disparities in exercise participation. Further research among underserved women is needed.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.